Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c (MAP_0882c)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c (MAP_0882c)

Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c (MAP_0882c) is an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a specific substrate. Methyltransferases are a large family of enzymes that play a role in many biological processes, including DNA methylation, protein methylation, and the biosynthesis of various metabolites . SAM-dependent methyltransferases utilize SAM as a cofactor .

Functional Analysis

  • Methylation Activity: MAP_0882c is predicted to be involved in methylation reactions. Methylation can alter the activity of proteins or DNA .

  • Substrate Specificity: Identifying the natural substrate of MAP_0882c is crucial for understanding its biological role. This can be achieved through biochemical assays and structural studies.

  • Enzyme kinetics: The catalytic efficiency of MAP_0882c can be determined by measuring the rate of methylation with respect to different substrate concentrations.

Role in Biological Processes

Based on sequence homology and functional studies, MAP_0882c may be involved in:

  • Metabolic Pathways: Participating in the biosynthesis or modification of specific metabolites.

  • Regulation: Modulating the activity of other proteins through methylation.

  • Stress Response: Altering protein function in response to environmental changes.

Experimental Techniques

Relevant experimental techniques for studying MAP_0882c include:

  • Recombinant Expression and Purification: Expressing the MAP_0882c gene in a suitable host organism (e.g., E. coli) and purifying the recombinant protein for in vitro studies.

  • Crystallography: Determining the three-dimensional structure of MAP_0882c by X-ray crystallography to understand its active site and substrate-binding mechanism .

  • Site-Directed Mutagenesis: Mutating specific amino acid residues in MAP_0882c to assess their roles in catalysis and substrate binding.

  • Mass Spectrometry: Identifying the methylated products of MAP_0882c using mass spectrometry.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type will be determined during the production process. If you require a specific tag type, please inform us; we will prioritize its development.
Synonyms
MAP_0882c; Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c; EC 2.1.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-304
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycobacterium paratuberculosis (strain ATCC BAA-968 / K-10)
Target Names
MAP_0882c
Target Protein Sequence
MTRSEGDTWN LASSVGATAT MVAAARAAAT RRPRPVLTDE YAEPLVRAVG LDVFTKLASG ELDPDDLERD VGFARMVDTF AARGRFYDDY FAAAGKAGVR QVVIVASGLD ARPYRLSWPA GTTVYEIDQP EVIAFKTATL SRIGAAPTAE LRTIGIDLRQ DWPAALQDAG FDPAQPTAWL AEGVLIGFLP PEAEVRLLDS ITPLSAEGSR FAADYGSLND ASQASTEQAR RTTEGWRRRG LDMDIAALTY PGKHTDVAAH LGADGWATTT FGLADLFAAA GLPELTEAEQ GPAATLSFVR AIKS
Uniprot No.

Target Background

Function
This recombinant protein exhibits S-adenosyl-L-methionine-dependent methyltransferase activity.
Database Links
Protein Families
UPF0677 family

Q&A

What is MAP_0882c and what organism does it come from?

MAP_0882c is a gene that encodes a putative S-adenosyl-L-methionine-dependent methyltransferase identified in Mycobacterium paratuberculosis, the causative agent of Johne's disease in cattle and other ruminants. This protein belongs to a class of enzymes that utilize S-adenosyl-L-methionine (SAM) as a methyl donor to catalyze methylation reactions. According to database records, MAP_0882c is classified under "Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c" in protein databases, indicating its predicted function has been assigned based on sequence homology rather than direct experimental validation .

What is the general structure and function of S-adenosyl-L-methionine-dependent methyltransferases?

S-adenosyl-L-methionine (SAM)-dependent methyltransferases share common structural elements despite diverse substrate specificities. These enzymes typically contain:

  • A characteristic Rossmann-like fold for SAM binding

  • Several conserved sequence motifs including:

    • Motif I (GxG) essential for SAM binding

    • Motif II (YxG) involved in substrate positioning

    • Motif III (RFINHxCxPN) participating in catalysis

    • Motif IV (ELxFDY) contributing to structural integrity

Functionally, these enzymes catalyze the transfer of a methyl group from SAM to various substrates including DNA, RNA, proteins, and small molecules. This methylation can alter molecular interactions, gene expression, protein function, or metabolite activity depending on the specific substrate. The reaction produces S-adenosyl-homocysteine (SAH) as a byproduct, which typically acts as a product inhibitor of these enzymes .

How conserved is MAP_0882c across mycobacterial species?

While the search results don't provide specific conservation data for MAP_0882c across mycobacterial species, we can infer several points from the available information:

  • MAP_0882c appears to be one of several putative methyltransferases in Mycobacterium paratuberculosis, as indicated by the existence of other related genes (MAP_0663, MAP_2076c, MAP_3385, MAP_3563, MAP_3881, MAP_4079, and MAP_4190c) .

  • S-adenosyl-L-methionine-dependent methyltransferases are widely distributed across bacteria, including mycobacteria, suggesting conservation of this enzyme class if not the specific protein.

  • To determine conservation of MAP_0882c specifically, researchers should:

    • Perform BLAST searches against mycobacterial genomes

    • Create multiple sequence alignments of putative homologs

    • Construct phylogenetic trees to visualize evolutionary relationships

    • Analyze genomic context to identify synteny (conservation of gene neighborhoods)

A comprehensive conservation analysis would provide insights into the evolutionary importance of this enzyme and help predict its functional significance in mycobacterial physiology or pathogenesis.

How can I express and purify recombinant MAP_0882c protein?

Expression and purification of recombinant MAP_0882c can be achieved using the following methodological approach:

Cloning strategy:

  • Amplify the MAP_0882c gene from Mycobacterium paratuberculosis genomic DNA using PCR with primers containing appropriate restriction sites

  • Clone the gene into an expression vector with an N- or C-terminal affinity tag (His, GST, etc.)

  • Verify the construct by sequencing to ensure no mutations were introduced

Expression systems:
According to product information, MAP_0882c has been successfully expressed in multiple systems:

  • E. coli

  • Yeast

  • Baculovirus-infected insect cells

  • Mammalian cells

Purification protocol:

  • Culture cells under optimized conditions (temperature, induction time, inducer concentration)

  • Harvest cells by centrifugation and lyse using sonication, French press, or detergents

  • Clarify lysate by centrifugation (20,000 × g, 30 min, 4°C)

  • Perform affinity chromatography:

    • For His-tagged protein: Ni-NTA or TALON resin

    • For GST-tagged protein: Glutathione Sepharose

  • Elute with appropriate buffer (imidazole for His-tag, reduced glutathione for GST-tag)

  • Further purify using size exclusion chromatography to remove aggregates and contaminants

  • Verify purity by SDS-PAGE and identity by western blotting or mass spectrometry

Quality control:

  • Verify protein folding using circular dichroism or fluorescence spectroscopy

  • Determine oligomeric state using analytical size exclusion chromatography

  • Assess enzymatic activity using appropriate methyltransferase assays

  • Evaluate protein stability by thermal shift assay

This approach is similar to methods used for other methyltransferases, such as the METTL21A methyltransferase described in the literature .

What assays can I use to determine the methyltransferase activity of MAP_0882c?

Several complementary approaches can be employed to assay the methyltransferase activity of MAP_0882c:

Radiometric assays:

  • Incubate purified MAP_0882c with [³H] or [¹⁴C]-labeled SAM and potential substrates

  • Separate reaction products by:

    • TCA precipitation for protein substrates

    • Filter binding for nucleic acid substrates

    • HPLC for small molecule substrates

  • Quantify incorporated radioactivity by scintillation counting

  • Advantages: high sensitivity, direct measurement of methyl transfer

  • Limitations: requires radioisotope handling, disposal concerns

Mass spectrometry-based assays:

  • Incubate enzyme with SAM and substrate under optimized conditions

  • Digest protein substrates with proteases for peptide-level analysis

  • Analyze by LC-MS/MS to identify:

    • Mass shifts of +14 Da indicating methylation

    • Location of methylation sites

    • Degree of methylation (mono-, di-, or tri-methylation)

  • Advantages: site-specific identification, quantitative analysis possible

  • Limitations: requires specialized equipment and expertise

Coupled enzymatic assays:

  • Link SAH production to a secondary reaction that produces a detectable signal

  • For example, the SAH generated can be converted to homocysteine by SAH nucleosidase, then to hydrogen sulfide by cystathionine β-lyase, which can react with a colorimetric reagent

  • Advantages: continuous monitoring, adaptable to high-throughput screening

  • Limitations: potential interference from coupling enzymes or compounds

Antibody-based detection:

  • Use antibodies specific to methylated residues (e.g., anti-methyl-lysine, anti-methyl-arginine)

  • Detect methylated products by western blot, ELISA, or immunofluorescence

  • Advantages: can be used for in vitro and cellular samples

  • Limitations: dependent on antibody specificity, may not detect all methylation sites

These methods have been successfully applied to characterize other methyltransferases, such as the novel protein arginine methyltransferase described in S. cerevisiae studies .

What are the optimal conditions for MAP_0882c enzymatic activity?

While specific optimal conditions for MAP_0882c have not been established in the provided search results, typical conditions for S-adenosyl-L-methionine-dependent methyltransferases provide a starting point for optimization:

Buffer composition:

ComponentTypical RangeNotes
BufferHEPES, Tris, or phosphatepH 7.0-8.5
NaCl50-150 mMAdjust for optimal ionic strength
MgCl₂1-5 mMMany methyltransferases require divalent cations
DTT or β-ME1-5 mMMaintains reduced state of cysteines
Glycerol5-10%Enhances protein stability
BSA0.1-1.0 mg/mlPrevents non-specific adsorption

Reaction parameters:

ParameterSuggested RangeOptimization Approach
Temperature30-42°CTest at 30°C, 37°C, and 42°C (relevant to mycobacterial growth)
pH7.0-9.0Test in 0.5 pH unit increments
[SAM]10-200 μMDetermine Km by varying concentration
[Substrate]Dependent on substrate typeTest multiple potential substrates
Enzyme concentration10-500 nMUse minimum amount that gives detectable activity
Incubation time15-120 minutesEstablish linearity of the reaction

Optimization strategy:

  • Perform initial activity screening using potential substrates

  • Once activity is detected, systematically vary each parameter while keeping others constant

  • Use statistical design of experiments (DoE) for efficient optimization

  • Determine kinetic parameters (Km, kcat) under optimal conditions

  • Test for potential activators or inhibitors

  • Verify optimal conditions across different substrate types if applicable

Similar systematic approaches have been used for characterizing other methyltransferases, such as the putative methyltransferase LaeA described in the literature .

How can I design an experiment to identify potential substrates of MAP_0882c?

Identifying the substrates of MAP_0882c requires a multi-faceted experimental design:

Bioinformatic prediction:

  • Analyze the protein structure and identify potential substrate-binding regions

  • Compare with characterized methyltransferases to infer substrate preferences

  • Examine genomic context for functional associations

  • Use protein-protein interaction networks to identify potential protein substrates

Candidate substrate screening:

  • Based on bioinformatic predictions, test likely substrate categories:

    • DNA (genomic DNA, methylation-sensitive restriction digestion)

    • RNA (total RNA, specific RNA classes)

    • Proteins (histones, transcription factors, metabolic enzymes)

    • Small molecules (metabolites, cell wall components)

  • Develop a medium-throughput screening assay that can detect methylation activity

  • Test systematically across substrate candidates

Unbiased substrate identification:

  • Activity-based protein profiling:

    • Synthesize SAM analogs with clickable or affinity handles

    • Incubate with cell lysate in the presence of MAP_0882c

    • Capture labeled substrates and identify by mass spectrometry

  • Comparative methylome analysis:

    • Generate MAP_0882c knockout or overexpression strains

    • Compare global methylation patterns using:

      • Methylation-specific antibodies

      • Mass spectrometry-based proteomics

      • Methylation-sensitive restriction enzyme analysis for DNA

  • Proximity labeling:

    • Create a MAP_0882c fusion with a promiscuous biotin ligase (BioID, TurboID)

    • Express in mycobacterial cells

    • Identify biotinylated proteins as potential interactors or substrates

Validation experiments:

  • Confirm direct methylation using purified components

  • Map methylation sites by mass spectrometry

  • Generate methylation-deficient mutants of the substrate

  • Assess functional consequences of methylation

This experimental design follows principles of optimal experimental design as described in the literature, with sequential refinement of hypotheses based on initial findings .

How does MAP_0882c compare structurally and functionally to other bacterial methyltransferases?

A comprehensive comparison of MAP_0882c with other bacterial methyltransferases would involve structural, sequence, and functional analyses:

Sequence comparison:
The S-adenosyl-L-methionine-dependent methyltransferase family exhibits considerable sequence diversity outside the conserved motifs. Comparing MAP_0882c to well-characterized methyltransferases reveals:

  • MAP_0882c contains 304 amino acids , within the typical range for bacterial methyltransferases

  • Like other mycobacterial proteins, it may contain specific sequence adaptations for its environment

  • Alignment with other methyltransferases would focus on:

    • Conservation of catalytic residues

    • Differences in substrate-binding regions

    • Presence of regulatory domains

Structural comparison:
While no experimental structure for MAP_0882c is reported in the search results, structural predictions could reveal:

  • Conservation of the core Rossmann-like fold for SAM binding

  • Unique structural features that might determine substrate specificity

  • Potential regulatory domains or protein-protein interaction interfaces

  • Comparison with structures of characterized methyltransferases such as:

    • DNA methyltransferases (e.g., Dam, Dcm)

    • Protein methyltransferases (e.g., PRMT family)

    • RNA methyltransferases

    • Small molecule methyltransferases

Functional comparison:
MAP_0882c function can be compared to other characterized methyltransferases:

  • DNA methyltransferases: Primarily involved in epigenetic regulation and protection against restriction enzymes

  • Protein methyltransferases: Like Rmt2 in yeast , modify proteins to alter their function, stability, or interactions

  • RNA methyltransferases: Modify rRNA, tRNA, or mRNA to affect translation or RNA stability

  • Small molecule methyltransferases: Participate in biosynthesis of antibiotics, cell wall components, or metabolites

A systematic comparison would help position MAP_0882c within the broader methyltransferase family and provide insights into its potential function in Mycobacterium paratuberculosis biology.

What role might MAP_0882c play in Mycobacterium paratuberculosis pathogenesis?

The potential role of MAP_0882c in pathogenesis can be investigated through several interconnected research approaches:

Genetic approaches:

  • Generate knockout mutants using specialized mycobacterial genetic tools

  • Evaluate phenotypic changes in:

    • Growth kinetics

    • Virulence in cell culture and animal models

    • Stress responses (pH, oxidative stress, nutrient limitation)

    • Drug susceptibility

  • Perform complementation studies to confirm phenotype specificity

  • Create point mutants targeting catalytic residues to confirm methyltransferase activity is responsible for the phenotype

Transcriptomic and proteomic analyses:

  • Compare gene expression profiles between wild-type and MAP_0882c mutants

  • Identify differentially regulated pathways, particularly those related to:

    • Cell wall synthesis

    • Metabolic adaptation

    • Immune evasion

    • Stress response

  • Examine expression of MAP_0882c itself under different conditions:

    • During infection

    • Under various stress conditions

    • In different growth phases

Substrate identification and characterization:

  • Identify methylation targets of MAP_0882c

  • Determine the functional consequences of methylation on these targets

  • Link methylation events to specific aspects of bacterial physiology or host interaction

Comparative analyses:

  • Analyze conservation of MAP_0882c across mycobacterial species

  • Compare virulence between strains with different expression levels of MAP_0882c

  • Examine the role of homologous methyltransferases in other pathogenic bacteria

Based on studies of other methyltransferases, MAP_0882c might contribute to pathogenesis through:

  • Modification of cell wall components to alter host recognition

  • Regulation of gene expression under stress conditions

  • Post-translational modification of virulence factors

  • Methylation of metabolites that interface with host immunity

This approach aligns with investigations of other bacterial methyltransferases where deletion mutants revealed phenotypes related to virulence, such as described for LaeA in fungal systems .

How can I implement a multiple-probe experimental design to study MAP_0882c function?

The multiple-probe experimental design (MPD) offers a robust framework for investigating MAP_0882c function in applied settings. This approach can be adapted from the PEAK relational training system described in the literature :

Experimental design structure:

  • Baseline probes:

    • Direct testing of MAP_0882c function before intervention

    • Measurement of methylation activity across multiple potential substrates

    • Assessment of growth phenotypes in wild-type organisms

  • Temporal staggering:

    • Introduction of interventions (gene knockout, inhibitor treatment, substrate modification) at different time points

    • Continuous monitoring of phenotypic outcomes

    • Maintenance of untreated controls throughout the experiment

  • Mastery criteria:

    • Establishment of clear endpoints for functional characterization

    • Definition of statistical thresholds for significant effects

    • Standardized protocols for phenotypic evaluation

Implementation for MAP_0882c:

PhaseComponentsMeasurementsAnalysis
Baseline- Wild-type cultures
- Multiple substrate candidates
- Control methyltransferase assays
- Growth curves
- Methyltransferase activity
- Gene expression levels
- Establish normal activity range
- Identify potential substrates
- Determine expression patterns
Intervention- MAP_0882c knockout
- MAP_0882c overexpression
- Site-directed mutants
- Enzyme inhibitors
- Changes in growth phenotype
- Substrate methylation levels
- Global methylation patterns
- Determine functional consequences
- Validate target specificity
- Assess compensatory mechanisms
Validation- Complementation studies
- In vitro reconstitution
- Host-pathogen models
- Restoration of phenotype
- Direct enzyme-substrate interaction
- Virulence assessment
- Confirm causal relationships
- Establish biochemical mechanisms
- Determine pathogenic relevance

Advantages of the MPD approach:

  • Allows direct testing of MAP_0882c function through multiple independent measures

  • Temporal staggering provides internal validation and controls for time-dependent effects

  • Clear mastery criteria establish when sufficient evidence has been gathered

  • The design can evolve based on initial findings

  • Failed experiments can be remedied through systematic adjustments

This experimental design aligns with the scientist-practitioner model described in the literature , enabling rigorous investigation while maintaining flexibility for practical constraints in mycobacterial research.

How do mutations in the SAM-binding motifs of MAP_0882c affect its function?

The effect of mutations in the SAM-binding motifs of MAP_0882c can be systematically investigated through a structure-function analysis approach:

Key SAM-binding motifs to target:

  • Motif I (GxG): Essential for SAM binding, creates a loop structure that accommodates the methionine portion of SAM

  • Motif II (YxG): Involved in positioning the substrate for methyl transfer

  • Motif III (RFINHxCxPN): Contains catalytically important residues

  • Motif IV (ELxFDY): Contributes to the structural integrity of the active site

Mutational strategy:

MotifMutations to TestPredicted Effects
I (GxG)G→A (conservative)
G→V (disruptive)
Reduced SAM binding affinity
Complete loss of SAM binding
II (YxG)Y→F (conservative)
Y→A (disruptive)
Altered substrate positioning
Loss of substrate recognition
III (RFINHxCxPN)R→K (conservative)
R→A (disruptive)
H→A (catalytic)
Reduced catalytic efficiency
Inactivation
Loss of proton transfer capability
IV (ELxFDY)E→D (conservative)
E→A (disruptive)
Minimal effect on structure
Destabilization of active site

Functional characterization:

  • Biochemical analysis:

    • Measure SAM binding affinity (isothermal titration calorimetry)

    • Determine enzyme kinetics (Km, kcat, catalytic efficiency)

    • Assess thermal stability (differential scanning fluorimetry)

    • Examine substrate specificity changes

  • Structural analysis:

    • Obtain crystal structures of wild-type and mutant proteins

    • Perform molecular dynamics simulations

    • Analyze changes in protein dynamics and flexibility

  • In vivo characterization:

    • Complement MAP_0882c knockout with mutant variants

    • Assess phenotypic rescue

    • Measure methylation activity in cellular context

    • Evaluate effects on bacterial physiology

Similar approaches have been successfully applied to other methyltransferases. For example, studies on the LaeA methyltransferase demonstrated that mutations in the SAM-binding domain (LaeAM1, LaeAM2, and LaeAM3) abolished its ability to regulate fungal physiology, confirming that methyltransferase activity is essential for its function .

How can I resolve conflicting data regarding the enzymatic activity of MAP_0882c?

Resolving conflicting data regarding MAP_0882c enzymatic activity requires a systematic approach combining critical evaluation, experimental validation, and reconciliation of different observations:

Critical evaluation of existing data:

  • Methodological differences:

    • Compare assay types (radiometric, mass spectrometry, coupled assays)

    • Examine reaction conditions (buffer composition, pH, temperature)

    • Review protein preparation methods (purification strategy, tags, storage)

    • Assess substrate sources and purity

  • Data quality assessment:

    • Evaluate statistical significance and reproducibility

    • Check for appropriate controls

    • Examine dose-response relationships

    • Consider potential artifacts or confounding factors

Targeted validation experiments:

  • Standardized conditions:

    • Establish uniform experimental protocols

    • Use consistent protein preparations

    • Test multiple substrate batches

    • Include positive and negative controls

  • Orthogonal methodologies:

    • Validate activity using independent assay techniques

    • Confirm substrate identity by multiple methods

    • Test in different biological contexts

    • Employ complementary structural analyses

Resolution approaches:

  • Multiple substrate hypothesis:

    • Test if MAP_0882c methylates different substrates under different conditions

    • Examine substrate competition

    • Measure relative activities toward different substrates

  • Regulatory mechanisms:

    • Investigate allosteric regulation

    • Test for post-translational modifications of MAP_0882c

    • Examine the effect of potential cofactors or binding partners

    • Study the effect of product inhibition

  • Structural flexibility:

    • Analyze if the enzyme adopts different conformations

    • Examine the effect of buffer components on structure

    • Test for oligomerization-dependent activity changes

Collaborative validation:

  • Exchange reagents and protocols between laboratories

  • Conduct blind validation experiments

  • Perform round-robin testing of the same samples

  • Develop consensus quality control criteria

This systematic approach aligns with the principles of optimal experimental design described in the literature , allowing for efficient resolution of conflicting data through sequential hypothesis testing and validation.

What bioinformatic approaches can predict MAP_0882c substrates and functions?

Predicting the substrates and functions of MAP_0882c requires an integrated bioinformatic approach combining sequence, structure, and systems biology methods:

Sequence-based approaches:

  • Homology analysis:

    • BLAST searches against characterized methyltransferases

    • Multiple sequence alignment to identify conserved catalytic residues

    • Phylogenetic analysis to place MAP_0882c within methyltransferase families

    • Examination of substrate-determining regions

  • Domain and motif analysis:

    • Identification of additional functional domains

    • Detection of substrate-binding motifs

    • Analysis of post-translational modification sites

    • Prediction of subcellular localization signals

Structure-based approaches:

  • Homology modeling:

    • Generation of 3D structural models using AlphaFold or similar tools

    • Validation of models using energy minimization and Ramachandran plots

    • Comparison with crystal structures of related methyltransferases

  • Active site analysis:

    • Identification of the substrate-binding pocket

    • Characterization of electrostatic and hydrophobic properties

    • Comparison with substrate-binding sites of characterized methyltransferases

    • Virtual screening of potential substrates

Systems biology approaches:

  • Genomic context analysis:

    • Examination of neighboring genes for functional associations

    • Identification of operons or regulons containing MAP_0882c

    • Comparative genomics across mycobacterial species

    • Analysis of gene fusion events

  • Network-based predictions:

    • Construction of protein-protein interaction networks

    • Pathway enrichment analysis of potential interactors

    • Co-expression analysis from transcriptomic data

    • Metabolic network analysis for small molecule substrates

Integrative analysis workflow:

  • Generate initial hypotheses using sequence-based methods

  • Refine predictions using structural modeling

  • Contextualize findings within biological networks

  • Prioritize candidate substrates for experimental validation

  • Design targeted assays based on bioinformatic predictions

This comprehensive bioinformatic approach leverages multiple lines of evidence to make informed predictions about MAP_0882c function, similar to the methodologies used to identify and characterize other methyltransferases in the literature .

How can I analyze the kinetics of MAP_0882c-catalyzed methylation reactions?

Analyzing the kinetics of MAP_0882c-catalyzed methylation reactions requires a systematic approach to determine reaction mechanisms and kinetic parameters:

Steady-state kinetic analysis:

  • Initial velocity measurements:

    • Measure reaction rates at varying substrate concentrations

    • Ensure linearity with respect to time and enzyme concentration

    • Maintain [S] >> [E] to satisfy steady-state assumptions

    • Include controls for background activity

  • Kinetic model fitting:

    • For single-substrate kinetics (considering SAM as constant):
      v=Vmax×[S]Km+[S]v = \frac{V_{max} \times [S]}{K_m + [S]}

    • For bi-substrate kinetics (varying both SAM and substrate):
      v=Vmax×[A]×[B]KiaKb+Kb[A]+Ka[B]+[A][B]v = \frac{V_{max} \times [A] \times [B]}{K_{ia}K_b + K_b[A] + K_a[B] + [A][B]}

    • Use non-linear regression for parameter estimation

  • Determination of kinetic parameters:

    • Km (substrate concentration at half-maximal velocity)

    • kcat (catalytic constant, turnover number)

    • kcat/Km (catalytic efficiency)

    • Ki values for inhibitors

Reaction mechanism determination:

  • Product inhibition studies:

    • Test inhibition by S-adenosylhomocysteine (SAH)

    • Determine competitive, uncompetitive, or mixed inhibition patterns

    • Analyze double-reciprocal plots for mechanism insights

  • Dead-end inhibitor studies:

    • Use SAM analogs to probe binding order

    • Test substrate analogs that bind but aren't methylated

    • Determine inhibition patterns to infer binding order

  • Isotope effects:

    • Measure kinetic isotope effects using deuterated substrates

    • Identify rate-limiting steps in the reaction

    • Probe transition state structures

Data analysis and visualization:

Plot TypePurposeInterpretation
Michaelis-MentenPrimary data visualizationDirect determination of Vmax and apparent Km
Lineweaver-Burk (double-reciprocal)Mechanism investigationPattern of lines indicates reaction mechanism
Eadie-HofsteeAlternative linearizationLess sensitive to errors at high substrate concentration
Dixon plotsInhibitor analysisDetermination of inhibition type and Ki values

Advanced kinetic analyses:

  • Pre-steady-state kinetics:

    • Use rapid kinetic techniques (stopped-flow, quench-flow)

    • Measure rates of individual steps in the reaction

    • Identify transient intermediates

    • Determine rate-limiting steps

  • Global data fitting:

    • Simultaneously fit multiple datasets to complex models

    • Use specialized software (DynaFit, KinTek Explorer)

    • Test alternative mechanisms statistically

    • Simulate reaction progress under various conditions

These methodologies follow established principles for enzyme kinetic analysis and can be applied to MAP_0882c to thoroughly characterize its catalytic mechanism and efficiency.

What are the potential applications of recombinant MAP_0882c in biotechnology?

Recombinant MAP_0882c, as a putative S-adenosyl-L-methionine-dependent methyltransferase, has several potential biotechnological applications beyond its use in basic research:

Synthetic biology applications:

  • Biosynthesis of methylated compounds:

    • Production of methylated natural products

    • Synthesis of methylated pharmaceuticals

    • Generation of methylated building blocks for chemical synthesis

    • Conversion of bio-based feedstocks to value-added methylated compounds

  • Pathway engineering:

    • Introduction of novel methylation capabilities into production organisms

    • Modification of existing methyltransferase specificity

    • Creation of new-to-nature methylated metabolites

    • Regulation of metabolic pathways through targeted methylation

Biotechnological tools:

  • Molecular biology applications:

    • Site-specific methylation of nucleic acids

    • Modulation of gene expression through targeted methylation

    • Creation of methylation-sensitive restriction sites

    • Development of methylation-based selection markers

  • Protein engineering:

    • Post-translational modification of recombinant proteins

    • Alteration of protein stability, solubility, or activity

    • Generation of methylated peptides for therapeutic applications

    • Development of methylation-sensitive biosensors

Diagnostic and analytical applications:

  • Biomarker analysis:

    • Detection of methylated biomolecules as disease markers

    • Quantification of methylation levels in clinical samples

    • Monitoring of methylation changes during disease progression

    • Development of methylation-specific analytical methods

  • Structural biology tools:

    • Methylation-assisted crystallization

    • Stabilization of proteins for structural studies

    • NMR analysis of methylated biomolecules

    • Mass spectrometry enhancement through methylation

Therapeutic applications:

  • Vaccine development:

    • Use as a component in subunit vaccines against mycobacterial diseases

    • Carrier protein for conjugate vaccines

    • Immunomodulatory effects through methylation of host factors

    • Attenuation of pathogens through methyltransferase modification

  • Drug development:

    • Target for antimycobacterial drugs

    • Screening platform for methyltransferase inhibitors

    • Production of methylated therapeutics

    • Enzyme replacement therapy for methylation disorders

These applications leverage the catalytic capabilities of MAP_0882c while considering its potential substrate specificity and reaction characteristics. As with any biotechnological application, thorough characterization of the enzyme's properties would be required before implementation in specific processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.